DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call
DaVita Inc. (NYSE: DVA) announced its quarterly conference call scheduled for October 28, 2022, at 8:30 a.m. ET, to discuss its third quarter results.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DaVita Inc. (NYSE: DVA) announced its quarterly conference call scheduled for October 28, 2022, at 8:30 a.m. ET, to discuss its third quarter results. The results will be released before the market opens on the same day. The call will be available via webcast on DaVita's IR webpage. As of June 30, 2022, DaVita served 198,000 patients at 2,808 outpatient dialysis centers in the U.S. and operates 349 outpatient dialysis centers in 11 countries. The company continues to focus on improving kidney care and quality of life for patients globally.
Positive
- Company scheduled a timely quarterly conference call to discuss Q3 results.
- DaVita serves a vast patient base of 198,000 patients in the U.S., highlighting its operational scale.
- Presence in 11 countries enhances its international reach and resilience.
Negative
- None.
Details
News Market Reaction – DVA
The recorded move for DVA in the trading session of this news was -0.12%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DENVER, Oct. 14, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.m. Eastern Time. The company plans to release its results before market open the same day.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Friday, October 28, 2022
Starting at 8:30 a.m. ET
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2022, DaVita served 198,000 patients at 2,808 outpatient dialysis centers in the United States. The company also operated 349 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-3rd-quarter-2022-investor-conference-call-301649311.html
SOURCE DaVita
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.